跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
优拓比 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Selexipag Tablets
Approved
化学药品
Selexipag Tablets
Actelion Pharmaceuticals Ltd
🇨🇳 National Medical Products Administration
Approval Date
Jul 24, 2023
Approval ID
8VIZZrGkjqx
Company
Actelion Pharmaceuticals Ltd
Type
化学药品
Approval Details
Approval Id
8VIZZrGkjqx
Approval Number
国药准字HJ20180082
Generic Name
司来帕格片
Generic Name En
Selexipag Tablets
Trade Name
优拓比
Drug Type
化学药品
Dosage Form
片剂
Strength
1mg
Reg Date
2023-07-24
Expired Date
2028-07-23
Company Name
Actelion Pharmaceuticals Ltd
Production Company Name
Excella GmbH & Co. KG
Company Detail Path
/organization/actelion-pharmaceuticals-ltd
Production Company Detail Path
/organization/excella-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 24, 2023
Approval ID
8VIZZrGkjqx
Type
化学药品
Back to NMPA Approvals